查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1833574

多丝纤维可吸收缝线市场预测至 2032 年：按类型、材料、涂层类型、分销管道、应用、最终用户和地区进行的全球分析

Multifilament Absorbable Sutures Market Forecasts to 2032 - Global Analysis By Type (Natural Multifilament Sutures, Synthetic Multifilament Sutures, and Other Types), Material, Coating Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球多丝纤维可吸收缝线市场预计在 2025 年达到 33.4 亿美元，到 2032 年将达到 65.1 亿美元，预测期内的复合年增长率为 10.0%。

多丝纤维可吸收缝线由多股线捻合而成，具有耐用性、柔韧性和牢固的结扎效果。它们会随着时间的推移自然降解并被身体吸收，无需拆线。它们通常用于缝合和结扎软组织，提供临时支撑。编织设计易于操作，可最大程度地减少组织刺激，并且比单链缝线更能有效地伤口缝合。

根据国际美容整形外科学会2024年6月发布的数据，2022年全球约有90万例鼻整形手术。到2023年，这一数字将增至110万例。

手术数量增加

癌症和心血管疾病等慢性疾病的增多，推动了医院手术的复杂化和微创化。机器人辅助系统和精密缝合工具等技术进步正在改善手术效果并缩短恢復时间。人口老化和诊断能力的提高，推动了已开发经济体和新兴经济体手术数量的成长。越来越多的外科医生选择可吸收缝线，以最大限度地减少术后併发症，并避免拆线。外科手术的激增直接推动了先进伤口缝合解决方案的发展。

与其他伤口缝合方法的竞争

替代性伤口缝合解决方案，例如手术缝合钉、医用黏合剂和伤口缝合胶带，正越来越多地被应用于各种临床环境。这些方法通常应用速度更快，组织创伤更小，挑战了传统缝线的优势。生物黏合剂和雷射闭合系统的创新正在重塑外科手术的偏好。此外，将智慧材料和抗菌涂层融入无缝缝合技术正引起临床偏好。医院正在寻求经济高效且省时的方案，尤其是在高通量环境下。随着这些方案的不断发展，它们在某些外科领域对多丝纤维可吸收缝线构成了竞争威胁。

某些外科专业的需求增加

整形外科、心血管外科和妇科等专科外科领域越来越多地采用多丝纤维可吸收缝线。这些缝合线具有卓越的打结安全性和抗拉强度，使其成为复杂组织缝合的理想选择。新兴趋势包括使用具有药物释放型特性的缝合线来促进癒合。外科医生还使用与机器人和腹腔镜平台相容的缝合线来进行精确缝合。随着个人化医疗的进步，专科手术也变得更加个人化，需要高性能的缝合材料。这种利基需求为技术创新和市场扩张提供了丰厚的机会。

易受供应链中断影响

多丝纤维可吸收缝线仍高度敏感，容易受到全球供应链波动的影响。由于其依赖专业原料和无菌包装，在地缘政治和经济不稳定时期，可能会导致生产延迟。医用聚合物短缺和运输瓶颈正在影响交货时间。製造商正在实施预测分析和数位物流工具，以降低这些风险。然而，劳动力短缺和区域性停工持续影响着业务永续营运。如果没有一个有弹性的供应链框架，企业可能会因关键外科产品供应不稳定而失去市场份额。

COVID-19的影响：

新冠疫情扰乱了外科手术流程，导致择期手术延期，缝合产品需求减少。封锁和工厂停工导致可吸收缝合线及相关外科用品短缺。然而，这场危机加速了数位转型，医院纷纷采用远距手术平台和远距离诊断。监管机构实施了紧急核准，以加快包括缝线在内的基本医疗设备的部署。疫情后的復苏强调自动化、分散式生产和库存弹性。这些转变正在重塑外科设备采购和使用的未来模式。

预计预测期间Polyglactin细分市场规模最大

预计Polyglactin线将在预测期内占据最大的市场份额。其均衡的吸收特性和高抗拉强度使其适用于广泛的外科手术应用。外科医生更倾向于使用Polyglactin缝合线进行软组织内缝合，因为其劣化可预测且组织反应极小。涂层技术和抗菌性能的创新进一步提升了Polyglactin缝合线的临床效用。该领域也受益于其在机器人手术和腹腔镜手术中的日益普及。随着手术量的增加，Polyglactin仍然是可靠的伤口缝合材料。

预计专科诊所部门在预测期内将见证最高的复合年增长率。

预计专科诊所细分市场将在预测期内实现最高成长率。这些机构越来越多地在门诊进行高阶手术，从而推动了对高性能缝合线的需求。紧凑型手术套件与云端基础库存系统的整合正在提高营运效率。诊所正在采用微创技术，并辅以符合人体工学的缝合工具和可生物降解材料。优惠的报销政策和更短的康復时间正在吸引更多患者前往专科中心。这种向分散式医疗的转变正推动这些诊所缝线消费的快速成长。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场份额。中国、印度和日本等国家正大力投资医疗基础设施和外科手术创新。政府推动本地生产和进口替代的措施正在提升区域生产能力。人工智慧辅助诊断和机器人手术在主要城市中心的应用正在加速。全球和国内公司之间的策略合作伙伴关係正在促进技术转移和市场渗透。

复合年增长率最高的地区：

在预测期内，北美凭藉其技术领先地位和强劲的研发投入，预计将呈现最高的复合年增长率。美国和加拿大正率先推出智慧手术室和人工智慧整合手术平台。监管机构正在简化下一代缝合材料的核准途径，以加快其市场准入速度。医院正在采用物联网工具来优化手术工作流程和资产利用率。微创手术的广泛采用和强大的报销框架正在推动市场发展。伤口缝合的创新。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球多丝纤维可吸收缝线市场（按类型）

  • 天然多丝纤维缝合线
  • 合成多丝纤维缝合线
  • 其他类型

6. 全球多丝纤维可吸收缝线市场（依材料）

  • Polyglactin
  • 氧环己酮聚合体（PDO）
  • Polyglycolic（PGA）
  • 聚乳酸（PLA）
  • 其他成分

7. 全球多丝纤维可吸收缝线市场（依涂层类型）

  • 涂层缝合线
  • 无涂层缝线

8. 全球多丝纤维可吸收缝线市场（依通路）

  • 直销
  • 经销商

9. 全球多丝纤维可吸收缝线市场（依应用）

  • 一般外科
  • 神经外科
  • 整形外科
  • 眼科手术
  • 妇科
  • 整容整形外科
  • 心臟病学
  • 其他用途

第 10 章全球多丝纤维可吸收缝线市场（依最终用户）

  • 医院和门诊手术中心（ASC）
  • 学术研究机构
  • 专科诊所
  • 其他最终用户

11. 全球多丝纤维可吸收缝线市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Johnson & Johnson
  • Sutures India Pvt Ltd
  • Medtronic
  • Surgical Specialties Corporation
  • B. Braun Melsungen AG
  • Internacional Farmaceutica
  • DemeTECH Corporation
  • Unilene
  • Smith & Nephew
  • Huaiyin Medical Instruments Co., Ltd.
  • Teleflex Incorporated
  • Assut Medical Sarl
  • Peters Surgical
  • Grena Ltd.
  • Lotus Surgicals
Product Code: SMRC31407

According to Stratistics MRC, the Global Multifilament Absorbable Sutures Market is accounted for $3.34 billion in 2025 and is expected to reach $6.51 billion by 2032 growing at a CAGR of 10.0% during the forecast period. Multifilament absorbable sutures consist of several twisted fibers, offering increased durability, flexibility, and secure knotting. Over time, they are naturally broken down and absorbed by the body, removing the need for extraction. Typically utilized for soft tissue stitching and ligation, they provide temporary support. The braided design enhances handling, minimizes tissue irritation, and ensures more effective wound closure than single-strand sutures.

According to data published by the International Society of Aesthetic Plastic Surgery in June 2024, around 0.9 million rhinoplasty procedures were performed worldwide in 2022. This number was increased to 1.1 million in 2023.

Market Dynamics:

Driver:

Increasing number of surgical procedures

As chronic diseases like cancer and cardiovascular conditions rise, hospitals are performing more complex and minimally invasive surgeries. Technological advancements such as robotic-assisted systems and precision suturing tools are improving procedural outcomes and reducing recovery times. Aging populations and better diagnostic capabilities are expanding surgical caseloads across both developed and emerging regions. Surgeons are increasingly opting for absorbable sutures to minimize post-operative complications and eliminate the need for removal. This surge in surgical activity is directly propelling the growth of advanced wound closure solutions.

Restraint:

Competition from alternative wound closure methods

Alternative wound closure solutions such as surgical staples, medical adhesives, and closure tapes are increasingly being adopted across various clinical settings. These methods often offer faster application and reduced tissue trauma, challenging the dominance of traditional sutures. Innovations in bioadhesives and laser-based closure systems are reshaping surgical preferences. Additionally, the integration of smart materials and antimicrobial coatings in non-suture closures is attracting clinical interest. Hospitals are exploring cost-effective and time-saving options, especially in high-throughput environments. As these alternatives evolve, they pose a competitive threat to multifilament absorbable sutures in certain surgical specialties.

Opportunity:

Rising demand in specific surgical specialties

Specialized surgical fields such as orthopedics, cardiovascular, and gynecology are witnessing increased adoption of multifilament absorbable sutures. These sutures offer superior knot security and tensile strength, making them ideal for complex tissue approximation. Emerging trends include the use of sutures embedded with drug-eluting properties for enhanced healing. Surgeons are also leveraging sutures compatible with robotic and laparoscopic platforms for precision closure. As personalized medicine advances, specialty procedures are becoming more tailored, requiring high-performance suturing materials. This niche demand is opening up lucrative opportunities for innovation and market expansion.

Threat:

Vulnerability to supply chain disruptions

The multifilament absorbable sutures remains highly sensitive to global supply chain fluctuations. Dependence on specialized raw materials and sterile packaging can lead to production delays during geopolitical or economic instability. Shortages in medical-grade polymers and transportation bottlenecks have impacted delivery timelines. Manufacturers are adopting predictive analytics and digital logistics tools to mitigate these risks. However, labor shortages and regional lockdowns continue to strain operational continuity. Without resilient supply chain frameworks, companies risk losing market share due to inconsistent availability of critical surgical products.

Covid-19 Impact:

The COVID-19 pandemic disrupted surgical workflows, delaying elective procedures and reducing demand for suturing products. Lockdowns and manufacturing halts led to shortages in absorbable sutures and related surgical supplies. However, the crisis accelerated digital transformation, with hospitals adopting tele-surgical platforms and remote diagnostics. Regulatory bodies introduced emergency approvals to fast-track essential medical devices, including sutures. Post-pandemic recovery is emphasizing automation, decentralized production, and inventory resilience. These shifts are reshaping the future landscape of surgical equipment procurement and utilization.

The polyglactinsegment is expected to be the largest during the forecast period

The polyglactinsegment is expected to account for the largest market share during the forecast period. Its balanced absorption profile and high tensile strength make it suitable for a wide range of surgical applications. Surgeons prefer polyglactin sutures for internal soft tissue approximation due to their predictable degradation and minimal tissue reaction. Innovations in coating technologies and antimicrobial enhancements are further boosting its clinical utility. The segment is also benefiting from increased usage in robotic and laparoscopic procedures. As surgical volumes rise, polyglactin continues to be the material of choice for reliable wound closure.

The specialty clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the specialty clinics segment is predicted to witness the highest growth rate. These facilities are increasingly performing advanced procedures in outpatient settings, driving demand for high-performance sutures. Integration of compact surgical kits and cloud-based inventory systems is enhancing operational efficiency. Clinics are adopting minimally invasive techniques supported by ergonomic suturing tools and biodegradable materials. Favorable reimbursement policies and shorter recovery times are attracting more patients to specialty centers. This shift toward decentralized care is fueling rapid growth in suture consumption within these clinics.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Countries like China, India, and Japan are investing heavily in healthcare infrastructure and surgical innovation. Government initiatives promoting local manufacturing and import substitution are boosting regional production capacity. The adoption of AI-assisted diagnostics and robotic surgery is accelerating across major urban centers. Strategic collaborations between global and domestic players are facilitating technology transfer and market penetration.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological leadership and robust R&D investment. The U.S. and Canada are pioneering smart operating rooms and AI-integrated surgical platforms. Regulatory agencies are streamlining approval pathways for next-gen suturing materials, encouraging faster market entry. Hospitals are adopting IoT-enabled tools to optimize surgical workflows and asset utilization. High adoption of minimally invasive procedures and strong reimbursement frameworks are reinforcing market momentum. As precision surgery becomes mainstream, North America continues to lead global innovation in wound closure technologies.

Key players in the market

Some of the key players in Multifilament Absorbable Sutures Market include Johnson & Johnson, Sutures India Pvt Ltd, Medtronic, Surgical Specialties Corporation, B. Braun Melsungen AG, InternacionalFarmaceutica, DemeTECH Corporation, Unilene, Smith &Nephew, Huaiyin Medical Instruments Co., Ltd., Teleflex Incorporated, Assut Medical Sarl, Peters Surgical, Grena Ltd., and Lotus Surgicals.

Key Developments:

In June 2021, Ethicon, a subsidiary of Johnson & Johnson Services, Inc., announced that the National Institute for Health and Care Excellence issued new medical technologies guidance (MTG59) recommending the use of Plus antibacterial sutures in surgeries within the healthcare system of the U.K.

Types Covered:

  • Natural Multifilament Sutures
  • Synthetic Multifilament Sutures
  • Other Types

Materials Covered:

  • Polyglactin
  • Polydioxanone (PDO)
  • Polyglycolic Acid (PGA)
  • Polylactic Acid (PLA)
  • Other Materials

Coating Types Covered:

  • Coated Sutures
  • Uncoated Sutures

Distribution Channels Covered:

  • Direct Sales
  • Distributors

Applications Covered:

  • General Surgery
  • Neurological Surgery
  • Orthopedic Surgery
  • Ophthalmic Surgery
  • Gynecology
  • Cosmetic & Plastic Surgery
  • Cardiology
  • Other Applications

End Users Covered:

  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Academic & Research Institutes
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Multifilament Absorbable Sutures Market, By Type

  • 5.1 Introduction
  • 5.2 Natural Multifilament Sutures
  • 5.3 Synthetic Multifilament Sutures
  • 5.4 Other Types

6 Global Multifilament Absorbable Sutures Market, By Material

  • 6.1 Introduction
  • 6.2 Polyglactin
  • 6.3 Polydioxanone (PDO)
  • 6.4 Polyglycolic Acid (PGA)
  • 6.5 Polylactic Acid (PLA)
  • 6.6 Other Materials

7 Global Multifilament Absorbable Sutures Market, By Coating Type

  • 7.1 Introduction
  • 7.2 Coated Sutures
  • 7.3 Uncoated Sutures

8 Global Multifilament Absorbable Sutures Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors

9 Global Multifilament Absorbable Sutures Market, By Application

  • 9.1 Introduction
  • 9.2 General Surgery
  • 9.3 Neurological Surgery
  • 9.4 Orthopedic Surgery
  • 9.5 Ophthalmic Surgery
  • 9.6 Gynecology
  • 9.7 Cosmetic & Plastic Surgery
  • 9.8 Cardiology
  • 9.9 Other Applications

10 Global Multifilament Absorbable Sutures Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Ambulatory Surgical Centers (ASCs)
  • 10.3 Academic & Research Institutes
  • 10.4 Specialty Clinics
  • 10.5 Other End Users

11 Global Multifilament Absorbable Sutures Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson
  • 13.2 Sutures India Pvt Ltd
  • 13.3 Medtronic
  • 13.4 Surgical Specialties Corporation
  • 13.5 B. Braun Melsungen AG
  • 13.6 Internacional Farmaceutica
  • 13.7 DemeTECH Corporation
  • 13.8 Unilene
  • 13.9 Smith & Nephew
  • 13.10 Huaiyin Medical Instruments Co., Ltd.
  • 13.11 Teleflex Incorporated
  • 13.12 Assut Medical Sarl
  • 13.13 Peters Surgical
  • 13.14 Grena Ltd.
  • 13.15 Lotus Surgicals

List of Tables

  • Table 1 Global Multifilament Absorbable Sutures Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Multifilament Absorbable Sutures Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Multifilament Absorbable Sutures Market Outlook, By Natural Multifilament Sutures (2024-2032) ($MN)
  • Table 4 Global Multifilament Absorbable Sutures Market Outlook, By Synthetic Multifilament Sutures (2024-2032) ($MN)
  • Table 5 Global Multifilament Absorbable Sutures Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 6 Global Multifilament Absorbable Sutures Market Outlook, By Material (2024-2032) ($MN)
  • Table 7 Global Multifilament Absorbable Sutures Market Outlook, By Polyglactin (2024-2032) ($MN)
  • Table 8 Global Multifilament Absorbable Sutures Market Outlook, By Polydioxanone (PDO) (2024-2032) ($MN)
  • Table 9 Global Multifilament Absorbable Sutures Market Outlook, By Polyglycolic Acid (PGA) (2024-2032) ($MN)
  • Table 10 Global Multifilament Absorbable Sutures Market Outlook, By Polylactic Acid (PLA) (2024-2032) ($MN)
  • Table 11 Global Multifilament Absorbable Sutures Market Outlook, By Other Materials (2024-2032) ($MN)
  • Table 12 Global Multifilament Absorbable Sutures Market Outlook, By Coating Type (2024-2032) ($MN)
  • Table 13 Global Multifilament Absorbable Sutures Market Outlook, By Coated Sutures (2024-2032) ($MN)
  • Table 14 Global Multifilament Absorbable Sutures Market Outlook, By Uncoated Sutures (2024-2032) ($MN)
  • Table 15 Global Multifilament Absorbable Sutures Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Multifilament Absorbable Sutures Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 17 Global Multifilament Absorbable Sutures Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 18 Global Multifilament Absorbable Sutures Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Multifilament Absorbable Sutures Market Outlook, By General Surgery (2024-2032) ($MN)
  • Table 20 Global Multifilament Absorbable Sutures Market Outlook, By Neurological Surgery (2024-2032) ($MN)
  • Table 21 Global Multifilament Absorbable Sutures Market Outlook, By Orthopedic Surgery (2024-2032) ($MN)
  • Table 22 Global Multifilament Absorbable Sutures Market Outlook, By Ophthalmic Surgery (2024-2032) ($MN)
  • Table 23 Global Multifilament Absorbable Sutures Market Outlook, By Gynecology (2024-2032) ($MN)
  • Table 24 Global Multifilament Absorbable Sutures Market Outlook, By Cosmetic & Plastic Surgery (2024-2032) ($MN)
  • Table 25 Global Multifilament Absorbable Sutures Market Outlook, By Cardiology (2024-2032) ($MN)
  • Table 26 Global Multifilament Absorbable Sutures Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 27 Global Multifilament Absorbable Sutures Market Outlook, By End User (2024-2032) ($MN)
  • Table 28 Global Multifilament Absorbable Sutures Market Outlook, By Hospitals & Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 29 Global Multifilament Absorbable Sutures Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 30 Global Multifilament Absorbable Sutures Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 31 Global Multifilament Absorbable Sutures Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.